​Allergan’s CEO pledges limited price hikes, says others have 'violated' social contract with big price increases

In response to public outcry over some drug companies that have drastically raised prices on medicines, the chief executive of Botox maker Allergan Plc pledged that his company would limit price increases on prescription drugs it makes. In a blog posting, CEO Brent Saunders called other drug companies that have engaged in price gouging “outliers” that are not only hurting patients but also harming investment and innovation. “The health care industry has had a long-standing unwritten social…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news